Pfizer strikes deal to allow generic versions of its Covid pill for world's poor

Under the licensing agreement, Pfizer will not receive royalties from the manufacturers, making the treatment cheaper See all our coronavirus coverage US pharmaceutical giant Pfizer has announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world's least-wealthy countries. Pfizer will allow generic manufacturers to supply its promising Paxlovid pill to 95 low-and middle-income nations covering about 53% of the world's population, the company said in a stat...